Literature DB >> 16303248

Delivery of hypericin for photodynamic applications.

Constance Lay Lay Saw1, Malini Olivo, Khee Chee Soo, Paul Wan Sia Heng.   

Abstract

Early cancer detection is critical in improving disease management outcomes. Cancer diagnosis presents unique difficulties mainly due to its pathological presentation and poor accessibility that could limit the usefulness of conventional white light endoscopy in early cancer detection. Fluorescence endoscopy has been proven to improve the sensitivity and specificity of early cancer detection. Hypericin (HY) has been found to be superior to 5-aminolevulinic acid (5-ALA) and its ester derivative hexaminolevulinate (HA) as a fluorescence diagnostic agent, hence its development for delivery in vitro and in vivo, is the subject of this review.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16303248     DOI： 10.1016/j.canlet.2005.10.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  5 in total

Review 1.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

2.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Accumulation and penetration behavior of hypericin in glioma tumor spheroids studied by fluorescence microscopy and confocal fluorescence lifetime imaging microscopy.

Authors:  Miriam C Bassler; Tim Rammler; Frank Wackenhut; Sven Zur Oven-Krockhaus; Ivona Secic; Rainer Ritz; Alfred J Meixner; Marc Brecht
Journal:  Anal Bioanal Chem       Date:  2022-05-10       Impact factor: 4.478

Review 4.  New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.

Authors:  Malini Olivo; Chit Yaw Fu; Vijaya Raghavan; Weber Kam On Lau
Journal:  Ann Biomed Eng       Date:  2011-11-29       Impact factor: 3.934

Review 5.  Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.

Authors:  Tomasz Kubrak; Michał Karakuła; Marcin Czop; Aleksandra Kawczyk-Krupka; David Aebisher
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.